Table 2.

Prevalence of medical comorbidities in patients with Sjögren’s syndrome (SS) compared with controls (n = 11,844). Data are number (%).

VariablePatients with SS, n = 1974Patients without SS, n = 9870p
Cardiovascular
  Hypertension478 (24.2)2332 (23.6)0.575
  Ischemic heart disease16 (0.8)77 (0.8)0.889
  Hyperlipidemia296 (15.0)1112 (11.3)< 0.001
  Congestive heart failure50 (2.5)251 (2.5)0.979
  Cardiac arrhythmias81 (4.1)311 (3.2)0.031
  Peripheral vascular disorder34 (1.7)118 (1.2)0.058
  Stroke119 (6.0)499 (5.1)0.076
Neurological
  Paralysis17 (0.9)68 (0.7)0.408
  Other neurological disorders42 (2.1)137 (1.4)0.014
  Headache398 (20.2)1449 (14.7)< 0.001
  Migraine51 (2.6)139 (1.4)< 0.001
  Epilepsy11 (0.6)61 (0.6)0.751
  Dementia30 (1.5)133 (1.4)0.549
  Multiple sclerosis1 (0.0)
  Polyneuropathy16 (0.8)48 (0.5)0.073
  Myasthenia gravis3 (0.2)2 (0.0)0.009
Rheumatology
  Fibromyalgia283 (143)888 (9.0)< 0.001
Pulmonary
  Chronic obstructive pulmonary disease9 (0.5)41 (0.4)0.799
  Asthma101 (5.1)335 (3.4)< 0.001
  Pulmonary circulation disorders214 (10.8)785 (8.0)< 0.001
Endocrine
  Diabetes without complications200 (10.1)941 (9.5)0.411
  Diabetes with complications80 (4.1)353 (3.6)0.303
  Hypothyroidism133 (6.7)293 (3.0)< 0.001
Renal
  Renal failure36 (1.8)136 (1.4)0.131
  Fluid and electrolyte disorders14 (0.7)86 (0.9)0.472
Gastrointestinal
  Liver disease223 (11.3)630 (6.4)< 0.001
  Peptic ulcer269 (13.6)777 (7.9)< 0.001
  Biliary cirrhosis2 (0.1)
Genitourinary
  Chronic interstitial cystitis/chronic cystitis3 (0.2)17 (0.2)0.841
Viral/infectious
  Hepatitis B91 (4.6)200 (2.0)< 0.001
  Tuberculosis15 (0.8)52 (0.5)0.208
  Urinary tract infection18 (0.9)57 (0.6)0.086
Hematology
  Deficiency anemias64 (3.2)242 (2.5)0.043
Mental illness
  Depression111 (5.6)225 (2.3)< 0.001
  Psychoses81 (4.1)193 (2.0)< 0.001
Oncology
  Metastatic cancer excluding lymphoma4 (0.2)12 (0.1)0.571
  Lymphoma5 (0.3)12 (0.1)0.158
  Solid tumor without metastasis74 (3.8)296 (3.0)0.081